Glymphatic inhibition exacerbates tau propagation in an Alzheimer’s disease model
Abstract Background The aggregation and spread of misfolded amyloid structured proteins, such as tau and α-synuclein, are key pathological features associated with neurodegenerative disorders, including Alzheimer’s and Parkinson’s disease. These proteins possess a prion-like property, enabling their...
Saved in:
| Main Authors: | Douglas M. Lopes, Jack A. Wells, Da Ma, Lauren Wallis, Daniel Park, Sophie K. Llewellyn, Zeshan Ahmed, Mark F. Lythgoe, Ian F. Harrison |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-04-01
|
| Series: | Alzheimer’s Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13195-024-01439-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impaired glymphatic clearance is an important cause of Alzheimer’s disease
by: Iyawnna Hazzard, et al.
Published: (2024-10-01) -
Sleep and Risk of Multiple Sclerosis: Bridging the Gap Between Inflammation and Neurodegeneration via Glymphatic Failure
by: Mariateresa Buongiorno, et al.
Published: (2025-07-01) -
Non-mutated human tau stimulates Alzheimer’s disease-relevant neurodegeneration in a microglia-dependent manner
by: Ethan R. Roy, et al.
Published: (2025-07-01) -
Assessment of the glymphatic dysfunction in amyotrophic lateral sclerosis using the diffusion tensor imaging along the perivascular spaces index: a pilot study
by: Seol-Hee Baek, et al.
Published: (2025-05-01) -
The Role of Tau in Neuronal Function and Neurodegeneration
by: Gonzalo Emiliano Aranda-Abreu, et al.
Published: (2025-05-01)